The private equity secondaries market recorded $162 billion in transaction volume for 2024, a 45% increase over 2023's $112 billion. The market has crossed into a new regime—one where episodic liquidity events have become continuous flow, where GP-led restructurings are standard portfolio management, and where the absence of public exit velocity makes secondaries not optional but necessary.
The volume split shows maturation. GP-led transactions—continuation vehicles and strip sales—comprised roughly $85 billion, or 52% of total activity. LP portfolio sales accounted for the remainder. Both categories grew year-over-year, but GP-led deals accelerated faster, reflecting sponsor comfort with structured liquidity rather than forced full exits. The average hold period for venture-backed companies now exceeds 13 years, and for buyout portfolio companies sits near 7.2 years, according to PitchBook data through Q3 2024. Sponsors no longer apologize for secondaries. They budget for them.
Three factors converged. First, the IPO window remained mostly closed. U.S. IPO proceeds in 2024 totaled approximately $28 billion, roughly half the 20-year average and a third of 2021's $142 billion. Second, strategic M&A valuations compressed. Median EV/EBITDA multiples for private equity exits via trade sale fell to 9.2x from 2021's 12.1x. Third, LP liquidity demands intensified. The denominator effect—private allocations swelling as public portfolios contracted—pushed institutions toward secondary sales to rebalance. CalPERS disclosed $4.2 billion in secondary sales in fiscal 2024 alone, part of a broader recalibration across state pensions.
The structural shift is that secondaries no longer signal distress. They signal portfolio construction. GPs use continuation funds to extend duration on high-conviction assets without forcing LPs into decade-plus commitments. LPs use portfolio sales to rotate capital without waiting for distributions that may not arrive for years. Pricing has tightened—average discounts to NAV narrowed to roughly 6-8% in 2024 from 12-15% in 2022, per Jefferies estimates. Volume at or above NAV is no longer rare. The market is professionalizing because it must.
Operators and allocators should watch three developments over the next 18 months. First, the composition of GP-led volume: if continuation vehicles begin representing 60%+ of total GP-led activity, that confirms duration extension is now default strategy, not exception. Second, the entrance of insurance capital into secondaries funds—$18 billion of the $52 billion raised in 2024 came from insurers seeking yield and illiquidity premium. Third, regulatory scrutiny on valuation practices. As secondaries pricing becomes public record through fund-level disclosures, the delta between reported NAV and transaction price will draw SEC attention. Expect formal guidance by mid-2026.
The market is no longer episodic. It is infrastructure. The question is not whether secondaries volume sustains, but whether pricing infrastructure and disclosure standards catch up to transaction velocity.